Drug Discovery

#Drug development #Drug discovery #Environmental impact #Guide #Lab of the future #Sustainability

Sustainability in the Lab: A Step-by-Step Guide

Download this guide to gain insights on the steps you can take to achieve a more sustainable lab without compromising quality or performance. Learn about: Conducting an assessment Choosing the right equipment Conserving water and reducing waste Engaging and educating your team… Read More

#Resources

A team working in a laboratory
#Biotech #Collaboration #Contract Research Organisations (CROs) #Drug discovery #Torx Software

Enhancing collaboration in drug discovery: Register now

Join DDW and Cresset for this free event ‘Enhancing collaboration in drug discovery – a biotech perspective’. The event will take place on 28 March at 2pm GMT / 3pm CET / 9am EST / 6am PST. Delivery of synthesis targets… Read More

#News

#Drug discovery

Webinar: Implementing rapid microbial identification in biotherapy manufacturing: Enhancing quality control and regulatory compliance 26.02.2024

In this webinar, hosted by DDW and sponsored by Thermo Fisher Scientific, we examine focused environmental monitoring within a cGMP facility. Specifically, leveraging the Applied Biosystems MicroSEQ Microbial Identification System in biotherapeutic manufacturing.  Microbial control within biopharmaceutical manufacturing is a critical quality control to help ensure drug products are free… Read More

#Webinars

#ALS #Drug discovery #Human disease models #iPSC #Neurology #Pluripotent stem cells #Stem cells

Using patient-specific cells for disease modelling

Induced pluripotent stem cell (iPSC)-derived cells are a significant resource for disease modelling. They allow the use of cells directly from affected patients and have the potential to guide these cells towards multiple lineages. Download the whitepaper to: Explore iPSC-derived motor neuron morphology Discover how ALS disease phenotype… Read More

#Resources

GBP pound sterling funding
#Alentis Therapeutics #Curve Therapeutics #Drug discovery #Finance #Funding #Pfizer Ventures #Seed funding #Solid tumours

£40.5 million invested in discovery platform and to advance pipeline 

Curve Therapeutics, a company developing an intracellular screening platform to address disease targets, has completed a £40.5 million ($51.37 million) Series A financing round. Pfizer Ventures led the round with participation from Columbus Venture Partners and British Patient Capital, which join founding investor Advent Life Sciences and… Read More

#News

#Automation / robotics #Drug discovery

Whitepaper: Bespoke Biosafety: Building a Custom Biosafety Cabinet

Simply having a biosafety cabinet (BSC) with large enough interior dimensions to house automation equipment is not always sufficient for ensuring proper airflow and adequate protection. In many cases, the equipment may actually interfere with the cabinet’s airflow, creating turbulence and rendering the cabinet ineffective. Download this whitepaper about customised… Read More

#Whitepapers

Gene editing concept
#CRISPR #CRISPR-Cas9 #Drug discovery #eBook #Gene editing #Genetics / genomics

New eBook: What does the future hold for gene editing & CRISPR?

Following the first regulatory approval of a CRISPR-based drug in late 2023, over ten years since the CRISPR-Cas9 system was elucidated, there is considerable optimism about the future potential for gene editing technologies. The astonishing pace of innovation has led to new, potentially safer CRISPR-based techniques, including… Read More

#News

#Advanced Therapies #Cell and gene therapy #Drug discovery #Webinar

DDW webinar: Achieve future success in cell and gene therapy

Hosted by DDW and sponsored by Astrea Bioseparations “Cell and gene therapies – how can market growth be sustained to maximise on opportunities” – will be free to attend on 28 February at 7AM PST / 10AM EST / 3PM GMT / 4PM CET.  … Read More

#News

Human liver
#Biosciences #Clinical trials #Drug discovery #Liver disease #Ochre Bio

Podcast: Unlock the potential of complex human liver data

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Quin Wills, Co-founder… Read More

#News

#Artificial intelligence (AI) #Drug discovery #Funding #Ginkgo #Immunology / Virology & Vaccines #Machine learning #Vaccine adjuvants

Ginkgo Bioworks to discover and develop novel vaccine adjuvants 

A five-year contract totalling up to $31 million including programme options has been awarded to Ginkgo Bioworks to discover and develop next-generation vaccine adjuvants. The contract was awarded by the Defense Threat Reduction Agency’s (DTRA) Joint Science and Technology Office (JSTO) for the Chemical and Biological Defense (CBD)… Read More

#News

Bill & Melinda Gates Foundation
#Bill & Melinda Gates Foundation #Drug development #Drug discovery #Finance #Funding #Mouse models #PhaSER Biomedical (PhaSER)

$2.3m Gates Foundation grant to accelerate global drug discovery 

Edinburgh-based PhaSER Biomedical (PhaSER) has received a Bill & Melinda Gates Foundation grant totalling $2.3m to continue its work in accelerating drug discovery and development.   PhaSER will provide 8HUM transgenic mouse models, humanised for key pathways involved in the metabolism and disposition of drugs, to all the… Read More

#News

#Advanced Therapies #Cell and gene therapy #Drug discovery #Webinar

DDW webinar: Global opportunities in cell and gene therapy

Hosted by DDW and sponsored by Astrea Bioseparations “Cell and gene therapies – how can market growth be sustained to maximise on opportunities” – will be free to attend on 28 February at 7AM PST / 10AM EST / 3PM GMT / 4PM CET.  … Read More

#News

Drug discovery innovation
#Drug discovery #ELRIG #Events #Medicines Discovery Catapult #Research

Keynotes announced for Research and Innovation 2024

The European Laboratory Research & Innovation Group (ELRIG) UK has announced the keynote speakers for its upcoming Research & Innovation conference: Steve Bates OBE FMedSci, CEO, BioIndustry Association (BIA) and Dr Anderson Ryan, Co-founder and Head of R&D and Drug Development, FasT BioPharma.   The event, taking place… Read More

#News

AI and robotics
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery

Is AI the answer to the challenges facing drug discovery?

DDW Editor Reece Armstrong asks whether artificial intelligence (AI) is the magic bullet many think it is. To reflect on another year in pharma is to think of the major stories and trends that have made impact within the industry. Often this can be drug approvals, exciting research… Read More

#Exclusive Content #Opinion

2024 predictions, road forward
#2024 predictions #AI / data analytics / healthtech / informatics #Antiverse #Artificial intelligence (AI) #Drug discovery #Elsevier #Enhanc3D Genomics #IQVIA #Lab automation #Machine learning #Medidata #Ori Biotech #Technology #TrakCel #Trinity Life Sciences

2024 predictions: Experts comment on AI, ML and automation

DDW’s Megan Thomas spoke to experts from the drug discovery industry about their predictions on what 2024 holds for our sector. This is part of a series of predictions based on different themes. Here, experts weigh in on the impact of artificial intelligence (AI), machine learning (ML) and automation in… Read More

#Exclusive Content #Opinion #Trends & Analysis